Reston – April 13, 2016 – Cooley advised Senseonics Holdings, Inc. on its $49.1 million initial public offering. The company now trades on the NYSE MKT under the symbol “SENS.”
Senseonics is a medical technology company focused on the design, development and commercialization of glucose monitoring systems to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy.
The Cooley corporate and securities team advising Senseonics included Darren DeStefano, Christian Plaza, Hosea Chang, Mark Ballantyne and Matt Schwee.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 900+ lawyers across 13 offices in the United States, China and Europe.